152 related articles for article (PubMed ID: 23306012)
1. T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma.
King AD; Keung CK; Yu KH; Mo FK; Bhatia KS; Yeung DK; Tse GM; Vlantis AC; Ahuja AT
AJNR Am J Neuroradiol; 2013; 34(6):1237-41. PubMed ID: 23306012
[TBL] [Abstract][Full Text] [Related]
2. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
[TBL] [Abstract][Full Text] [Related]
4. Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
Noij DP; Jagesar VA; de Graaf P; de Jong MC; Hoekstra OS; de Bree R; Castelijns JA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):296-305.e2. PubMed ID: 28539202
[TBL] [Abstract][Full Text] [Related]
5. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.
King AD; Chow KK; Yu KH; Mo FK; Yeung DK; Yuan J; Bhatia KS; Vlantis AC; Ahuja AT
Radiology; 2013 Feb; 266(2):531-8. PubMed ID: 23151830
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.
Hwang I; Choi SH; Kim YJ; Kim KG; Lee AL; Yun TJ; Kim JH; Sohn CH
AJNR Am J Neuroradiol; 2013 Dec; 34(12):2343-8. PubMed ID: 23811978
[TBL] [Abstract][Full Text] [Related]
7. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
9. Comparison of diffusion-weighted MR imaging and
Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY
Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403
[TBL] [Abstract][Full Text] [Related]
10. Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy.
Matoba M; Tuji H; Shimode Y; Toyoda I; Kuginuki Y; Miwa K; Tonami H
AJNR Am J Neuroradiol; 2014 Feb; 35(2):379-85. PubMed ID: 24029391
[TBL] [Abstract][Full Text] [Related]
11. Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.
Srinivasan A; Chenevert TL; Dwamena BA; Eisbruch A; Watcharotone K; Myles JD; Mukherji SK
J Comput Assist Tomogr; 2012; 36(1):131-7. PubMed ID: 22261783
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy.
Hatakenaka M; Nakamura K; Yabuuchi H; Shioyama Y; Matsuo Y; Ohnishi K; Sunami S; Kamitani T; Setoguchi T; Yoshiura T; Nakashima T; Nishikawa K; Honda H
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):339-45. PubMed ID: 20832179
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
[TBL] [Abstract][Full Text] [Related]
14. Detection of Local Tumor Recurrence After Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Histogram Analysis of Dynamic Contrast-Enhanced T1-Weighted Perfusion MRI.
Choi SH; Lee JH; Choi YJ; Park JE; Sung YS; Kim N; Baek JH
AJR Am J Roentgenol; 2017 Jan; 208(1):42-47. PubMed ID: 27680294
[TBL] [Abstract][Full Text] [Related]
15. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive prediction of the tumor growth rate using advanced diffusion models in head and neck squamous cell carcinoma patients.
Fujima N; Sakashita T; Homma A; Harada T; Shimizu Y; Tha KK; Kudo K; Shirato H
Oncotarget; 2017 May; 8(20):33631-33643. PubMed ID: 28430583
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.
Prezzi D; Muthuswamy K; Amlani A; Owczarczyk K; Elowaidy A; Mistry T; Bassett P; Goh V
Eur Radiol; 2023 Nov; 33(11):7575-7584. PubMed ID: 37462820
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
Hoang JK; Choudhury KR; Chang J; Craciunescu OI; Yoo DS; Brizel DM
AJR Am J Roentgenol; 2014 Nov; 203(5):1104-8. PubMed ID: 25341151
[TBL] [Abstract][Full Text] [Related]
20. Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect.
Kato H; Kanematsu M; Tanaka O; Mizuta K; Aoki M; Shibata T; Yamashita T; Hirose Y; Hoshi H
Eur Radiol; 2009 Jan; 19(1):103-9. PubMed ID: 18641991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
